This brain regions play a role in adaptive responses of the hypothalamic-pituitary-adrenal axis (HPA axis) to fear-inducing stimuli (239, 246, 296)
Because this longer-lasting effect makes it a candidate for therapies aimed at muscle tone, tissue repair, skin quality, and even metabolic balance
Because of this, certain medications that act on metabolic systems, including GLP-1 receptor agonists, are being included in the conversation surrounding management of menopause symptoms
A published real-world study (Advances in Therapy, 2025) documented mean weight loss of 14.1% for semaglutide and 16.5% for tirzepatide over one year in nearly 10,000 patients on FDA-approved formulations - these research figures are not specific to compounded programs or to WellMedr
& Christofk, H
Theyre made by the same pharmaceutical company, Novo Nordisk